Dr. Mary Pinder of Moffitt Cancer Center reviews the CUSTOM
trial, in which the study of molecular markers was expanded to
patients with small cell lung cancer and thymic carcinomas.
About the Podcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.